AstraZeneca and the University of Oxford announced on Monday that their inexpensive, easy-to-produce coronavirus vaccine appears effective, the latest in a string of encouraging results this month from leading vaccine developers. An early analysis of data from late-stage clinical trials found that AstraZeneca’s vaccine was either 62 percent or 90 …
Read More »AstraZeneca’s Coronavirus Vaccine, Easy and Cheap to Produce, Appears Effective
